UNICANCER: all 219 studies
Page 1 of 3. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.
- Investigating Precision Medicine in the Adjuvant Setting in Biliary Tract CancerNot yet recruitingNCT07745296Phase 3
- Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.Not yet recruitingNCT07717450Phase 3
- Study to Evaluate the Efficacy of Zanzalintinib in the Treatment of Relapsed or Metastatic Adenoid Cystic Carcinomas of the Head and NeckNot yet recruitingNCT07682675Phase 2
- Skipping Hormone Therapy in Low-Risk Early Breast CancerRecruitingNCT07661927Phase 2
- Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract CancersNot yet recruitingNCT07437287Phase 2/3
- Immunotherapy Master Trial for Advanced CancersRecruitingNCT07431073Phase 2
- Study Aiming to Test Whether Non-invasive Liquid Biopsies Can Safely Reduce Invasive Surveillance Methods in Lynch SyndromeNot yet recruitingNCT07360834Not applicable
- Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 LevelsRecruitingNCT07360743Phase 2
- Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver MetastasesNot yet recruitingNCT07359456Phase 2
- Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.Not yet recruitingNCT07340619Phase 2
- Antibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate.Not yet recruitingNCT07294430Phase 2
- Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk of Recurrence of Their DiseaseNot yet recruitingNCT07284394Phase 3
- Neo-adjuvant Immunotherapy Master Trial for Localized CancersRecruitingNCT07262489Phase 2
- Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful BiomarkersRecruitingNCT07259226Phase 2
- SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal CancerNot yet recruitingNCT07241273Not applicable
- Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant RibociclibRecruitingNCT07237256Phase 3
- Neo-adjuvant Immunotherapy in Patients With Localized MelanomaRecruitingNCT07230613Phase 2
- Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.RecruitingNCT07192068Phase 2
- Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predicted RiskRecruitingNCT07187726Not applicable
- Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast CancerNot yet recruitingNCT07151586Phase 2
- Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.RecruitingNCT07120087Not applicable
- Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years OldNot yet recruitingNCT07118800Phase 3
- Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic TestsRecruitingNCT07106632Phase 3
- Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular CarcinomaRecruitingNCT06904170Phase 2/3
- Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal AdenocarcinomaRecruitingNCT06846346Phase 2
- Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd TherapyEnrolling by invitationNCT06680596Phase 2
- Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor CellsRecruitingNCT06653777Phase 2
- Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of RelapseRecruitingNCT06625970Phase 3
- Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast CancerRecruitingNCT06606730Phase 3
- Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer PatientsRecruitingNCT06529718Phase 2
- Blood Biomarkers Based Screening for HPV-driven OPCNot yet recruitingNCT06528353Not applicable
- Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the TumourRecruitingNCT06524583Phase 2
- Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)RecruitingNCT06496581Phase 3
- Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver EnzymeRecruitingNCT06475352Phase 2
- Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests.RecruitingNCT06450314Phase 2
- Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIRecruitingNCT06333314Phase 2
- Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional ImagingRecruitingNCT06276465Phase 3
- Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal CancerRecruitingNCT06245356Phase 2
- Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBCRecruitingNCT06078384Phase 2
- Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and SurgeryRecruitingNCT05973864Phase 2
- Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal DiseaseRecruitingNCT05800275Phase 2
- A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal CancerRecruitingNCT05639413Not applicable
- Personalized Medicine for Advanced Biliary Cancer PatientsRecruitingNCT05615818Phase 3
- SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal CancersRecruitingNCT05582122Phase 2
- TARGETed Therapy Drug MONITOring in DIGestive OncologyRecruitingNCT05443087Not applicable
- Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low RiskRecruitingNCT05297617Phase 2
- ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)RecruitingNCT04916613Phase 3
- Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma PatientsRecruitingNCT04757337Phase 3
- Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck CancersRecruitingNCT04747054Phase 3
- Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)RecruitingNCT03848052
- Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008RecruitingNCT03275311
- Chronic Toxicities Related to Treatment in Patients With Localized CancerRecruitingNCT01993498Not applicable
- Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal AdenocarcinomaCompletedNCT03943667Phase 3Results posted
- Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast CancerCompletedNCT00630032Phase 3Results posted
- Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell TumorsCompletedNCT00104676Phase 3Results posted
- Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood TestActive, not recruitingNCT07340567Phase 3
- Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line TreatmentTerminatedNCT06505018Not applicable
- Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or RibociclibTerminatedNCT05625087Phase 2
- Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver FunctionsCompletedNCT05622071Phase 2
- Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the ThoraxActive, not recruitingNCT05617963Phase 2
- Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast CancerActive, not recruitingNCT05552001Phase 3
- Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction CancerActive, not recruitingNCT05476796Phase 2
- Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IOActive, not recruitingNCT05078047Phase 3
- Patient's Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast CancerCompletedNCT05058196Not applicable
- Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast CancerActive, not recruitingNCT05041842Phase 2
- Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPCCompletedNCT04725396Not applicable
- Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal CancerTerminatedNCT04450836Phase 2
- Evaluation of Bintrafusp Alfa in Operable and Untreated Head and Neck Squamous Cell CarcinomaTerminatedNCT04428047Phase 2
- COVID-19 Detection Test in OncologyCompletedNCT04367870
- Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different LocationsCompletedNCT04357873Phase 2
- Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast CancerCompletedNCT04246606
- Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After ProstatectomyActive, not recruitingNCT04181203Phase 3
- Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast CancerActive, not recruitingNCT04158362Phase 3
- Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers AnalysisCompletedNCT04132960Phase 2
- Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive PatientsActive, not recruitingNCT04115007Phase 3
- Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain MetastasisActive, not recruitingNCT04074096Phase 2
- Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.Active, not recruitingNCT04053322Phase 2
- Impact of Immunoscore Colon Test on Adjuvant Therapeutic Strategy in Non-Metastatic Colon CancerWithdrawnNCT03946033Not applicable
- Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma BreastActive, not recruitingNCT03878342Not applicable
- Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer PatientsActive, not recruitingNCT03870919Not applicable
- Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx CancerCompletedNCT03838263Phase 2
- Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer PatientsWithdrawnNCT03809455Phase 2
- Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer PatientsActive, not recruitingNCT03799835Phase 3
- Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcerCompletedNCT03777813Phase 2
- PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung CancerActive, not recruitingNCT03774732Phase 3
- Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy.SuspendedNCT03722680Phase 2
- Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal AdenocarcinomasTerminatedNCT03722108Phase 1/2
- Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical CystectomyActive, not recruitingNCT03697850Phase 2
- My Personalized Breast ScreeningActive, not recruitingNCT03672331Not applicable
- Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma PatientsActive, not recruitingNCT03643133Phase 2
- Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal CancerWithdrawnNCT03532204Not applicable
- Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid TumoursCompletedNCT03518606Phase 1/2
- Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor RecurrenceActive, not recruitingNCT03438552Not applicable
- Identifying the Predictive Factors of Response to PD-1 or PD-L1 AntagonistsTerminatedNCT03412058Not applicable
- SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast CancerTerminatedNCT03386162Phase 2
- Study on Androgen Receptor and Triple Negative Breast CancerCompletedNCT03383679Phase 2
- Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30)Active, not recruitingNCT03333356Not applicable
- A Patient Consensus for the Research in Supportive Care in French Cancer Care Centers: the CyPRES ProjectCompletedNCT03320161
- Evolution of the Therapeutic Care in Ovarian Cancer From 2011SuspendedNCT03275298
- Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.Active, not recruitingNCT03246841Not applicable